Publication | Open Access
Sirolimus enhances remission induction in patients with high risk acute myeloid leukemia and mTORC1 target inhibition
19
Citations
18
References
2018
Year
Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaImmunologyPharmacologyMyeloid NeoplasiaMtorc1 Target InhibitionImmune Checkpoint InhibitorRemission InductionOncologyRadiation OncologyCancer ResearchHigh Risk
| Year | Citations | |
|---|---|---|
Page 1
Page 1